Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
896
archived clinical trials in
Gastroesophageal Reflux Disease

The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Status: Enrolling
Updated:  12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Status: Enrolling
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients
Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients
Status: Enrolling
Updated:  2/6/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients
Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients
Status: Enrolling
Updated: 2/6/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Tricyclic Antidepressants (TCAs) on Gastric Emptying
Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying
Status: Enrolling
Updated:  2/8/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Tricyclic Antidepressants (TCAs) on Gastric Emptying
Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying
Status: Enrolling
Updated: 2/8/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome
Effectiveness of Tongue Exercises and Laryngopharyngeal Reflux Therapy on Upper Airway Resistance Syndrome
Status: Enrolling
Updated:  8/11/2006
West Side ENT
mi
from
New York, NY
Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome
Effectiveness of Tongue Exercises and Laryngopharyngeal Reflux Therapy on Upper Airway Resistance Syndrome
Status: Enrolling
Updated: 8/11/2006
West Side ENT
mi
from
New York, NY
Click here to add this to my saved trials
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Status: Enrolling
Updated:  11/27/2006
Lucile Packard Childrens Hospital
mi
from
Stanford, CA
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
Status: Enrolling
Updated: 11/27/2006
Lucile Packard Childrens Hospital
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)
Diagnosis and Response to Treatment of Laryngopharyngeal Reflux Using an Oropharyngeal Aerosolized pH Probe
Status: Enrolling
Updated:  11/20/2007
Emory Voice Center
mi
from
Atlanta, GA
Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)
Diagnosis and Response to Treatment of Laryngopharyngeal Reflux Using an Oropharyngeal Aerosolized pH Probe
Status: Enrolling
Updated: 11/20/2007
Emory Voice Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Acid Reflux Therapy for Children With Asthma
Study of Acid Reflux Therapy for Children With Asthma
Status: Enrolling
Updated:  1/17/2008
Emory Children's Center
mi
from
Atlanta, GA
Study of Acid Reflux Therapy for Children With Asthma
Study of Acid Reflux Therapy for Children With Asthma
Status: Enrolling
Updated: 1/17/2008
Emory Children's Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status: Enrolling
Updated:  1/20/2010
San Antonio Military Medical Center - North
mi
from
San Antonio, TX
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status: Enrolling
Updated: 1/20/2010
San Antonio Military Medical Center - North
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status: Enrolling
Updated:  1/20/2010
San Antonio Military Medical Center - South
mi
from
San Antonio, TX
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status: Enrolling
Updated: 1/20/2010
San Antonio Military Medical Center - South
mi
from
San Antonio, TX
Click here to add this to my saved trials
Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
Assessment of the Effects of Zegerid Powder for Oral Suspension 40 mg on 24-Hour and Nocturnal Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease and Barrett's Esophagus
Status: Enrolling
Updated:  5/24/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
Assessment of the Effects of Zegerid Powder for Oral Suspension 40 mg on 24-Hour and Nocturnal Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease and Barrett's Esophagus
Status: Enrolling
Updated: 5/24/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD
The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With Gastroesophageal Reflux Disease (GERD).
Status: Enrolling
Updated:  8/18/2010
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD
The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With Gastroesophageal Reflux Disease (GERD).
Status: Enrolling
Updated: 8/18/2010
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia (BPD).
Status: Enrolling
Updated:  11/9/2010
UT-Houston Pediatric Surgery & Memorial Hermann Children's Hospital
mi
from
Houston, TX
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia (BPD).
Status: Enrolling
Updated: 11/9/2010
UT-Houston Pediatric Surgery & Memorial Hermann Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Serial Exhaled Breath pH Monitoring
Serial Exhaled Breath pH Monitoring
Status: Enrolling
Updated:  3/4/2011
University of Virginia
mi
from
Charlottesville, VA
Serial Exhaled Breath pH Monitoring
Serial Exhaled Breath pH Monitoring
Status: Enrolling
Updated: 3/4/2011
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
Evaluation of Esophageal and Gastric Acid Levels in Patients Presenting With Upper Gastrointestinal Symptoms Using a Novel PH System
Status: Enrolling
Updated:  3/21/2011
Department of Veterans Affairs Medical Center
mi
from
Kansas City, MO
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
Evaluation of Esophageal and Gastric Acid Levels in Patients Presenting With Upper Gastrointestinal Symptoms Using a Novel PH System
Status: Enrolling
Updated: 3/21/2011
Department of Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Status: Enrolling
Updated:  3/31/2011
Univ of Washington
mi
from
Seattle, WA
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Status: Enrolling
Updated: 3/31/2011
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
A Randomized, Double-blind, Placebo-controlled Study of Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
Status: Enrolling
Updated:  4/4/2011
Advanced Center for Specialty Care
mi
from
Chicago, IL
Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
A Randomized, Double-blind, Placebo-controlled Study of Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
Status: Enrolling
Updated: 4/4/2011
Advanced Center for Specialty Care
mi
from
Chicago, IL
Click here to add this to my saved trials
Cough Monitoring Study
Monitoring Cough Device - Step 1 and 2
Status: Enrolling
Updated:  7/11/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Cough Monitoring Study
Monitoring Cough Device - Step 1 and 2
Status: Enrolling
Updated: 7/11/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients
A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients
Status: Enrolling
Updated:  4/4/2012
Kansas City VA Medical Center
mi
from
Kansas City, MO
A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients
A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients
Status: Enrolling
Updated: 4/4/2012
Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pepsin As A Biomarker For Aspiration
Pepsin as a Biomarker for Aspiration Due to Gastroesophageal Reflux
Status: Enrolling
Updated:  4/12/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Pepsin As A Biomarker For Aspiration
Pepsin as a Biomarker for Aspiration Due to Gastroesophageal Reflux
Status: Enrolling
Updated: 4/12/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparative Anti-Reflux Procedures in Neurologically Impaired Children
Comparative Anti-Reflux Procedures in Neurologically Impaired Children
Status: Enrolling
Updated:  6/1/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Comparative Anti-Reflux Procedures in Neurologically Impaired Children
Comparative Anti-Reflux Procedures in Neurologically Impaired Children
Status: Enrolling
Updated: 6/1/2012
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prospective Pediatric Vesicoureteral Reflux Surgery Database
Prospective Pediatric Vesicoureteral Reflux Surgery Database
Status: Enrolling
Updated:  7/3/2012
Connecticut Children's Medical Center
mi
from
Hartford, CT
Prospective Pediatric Vesicoureteral Reflux Surgery Database
Prospective Pediatric Vesicoureteral Reflux Surgery Database
Status: Enrolling
Updated: 7/3/2012
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Status: Enrolling
Updated:  7/24/2012
University of California, Davis Medical Center
mi
from
Sacramento, CA
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
Status: Enrolling
Updated: 7/24/2012
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)
Evaluation of Distal Esophageal and Cardia Rubber Band Ligation and Mucosectomy in the Treatment of Subjects With Gastroesophageal Reflux Disease
Status: Enrolling
Updated:  9/28/2012
Indiana University Hospital
mi
from
Indianapolis, IN
Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)
Evaluation of Distal Esophageal and Cardia Rubber Band Ligation and Mucosectomy in the Treatment of Subjects With Gastroesophageal Reflux Disease
Status: Enrolling
Updated: 9/28/2012
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic
mi
from
Phoenix, AZ
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic - Jacksonville
mi
from
Jacksonville, FL
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Northwestern University Chicago
mi
from
Chicago, IL
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Northwestern University Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated:  11/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Functional Dyspepsia Treatment Trial
Antidepressant Therapy for Functional Dyspepsia
Status: Enrolling
Updated: 11/7/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
HOPE Research Institute
mi
from
Phoenix, AZ
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Genova Clinical Research
mi
from
Tucson, AZ
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Genova Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Arkansas Gastroenterology
mi
from
Sherwood, AR
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Arkansas Gastroenterology
mi
from
Sherwood, AR
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Southern California Research Institute Medical Group Inc
mi
from
Los Angeles, CA
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Southern California Research Institute Medical Group Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Medical Center for clinical research
mi
from
San Diego, CA
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Clinicos, LLC
mi
from
Colorado Springs, CO
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Clinicos, LLC
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Medical Research Unlimited
mi
from
Hialeah, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Medical Research Unlimited
mi
from
Hialeah, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Consultants for Clinical Research of South Florida
mi
from
Boynton Beach, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Consultants for Clinical Research of South Florida
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
PAB Clinical Research
mi
from
Brandon, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Avail Clinical Research
mi
from
DeLand, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
S&W Clinical Research
mi
from
Fort Lauderdale, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
S&W Clinical Research
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Jupiter Research
mi
from
Jupiter, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Jupiter Research
mi
from
Jupiter, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Radiant Research, Inc.
mi
from
Pinellas Park, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Radiant Research, Inc.
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated:  11/7/2012
Accord Clinical Research
mi
from
Port Orange, FL
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate Efficacy of a Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) With Persistent Regurgitation With or Without Heartburn
Status: Enrolling
Updated: 11/7/2012
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials